Treatment · May 21, 2026
Health Canada Reviews First New Class of Acute Pain Drug in Over 20 Years
Vertex's pain relief drug suzetrigine advances with Health Canada review for treating moderate-to-severe acute pain....
Treatment · April 21, 2026
FDA Clears Investigational Drug for Chemotherapy Pain and Neuropathy
Dogwood Therapeutics receives FDA approval to advance its SP16 cancer program, moving closer to potential patient treatment....